INTRODUCTION
Wounds in general, and especially burns, are hypoxic. 1 Restoration of cellular homeostasis in the hypoxic environment is orchestrated by the transcription factor hypoxia-inducible factor-1 (HIF-1). 2 Assessment of HIF-1 function in aged mice has shown decreased function, 3 decreased stabilization 4, 5 and decreased protein levels, 6 as well as reduced synthesis of angiogenic and vasculogenic transcription products. [3] [4] [5] [6] [7] [8] [9] There is strong evidence for the role of HIF-1 in the release and homing of circulating angiogenic cells from the bone marrow. [9] [10] [11] As expected by the deficiency of HIF-1 in wounds of the elderly, bone marrow cell mobilization during wound healing is also impaired by aging. 6 The delay in wound healing in the elderly is associated with reduced blood flow to the wounds. 6 It is possible that the deficiency of HIF-1 is playing a major part in the impaired wound healing and angiogenesis in the elderly.
Addressing the problem of diminished levels of HIF-1 in the elderly is an attractive strategy for improving wound healing in the elderly. 12 Normally, HIF-1 is rapidly hydroxylated and degraded in the presence of normoxia. A normoxia-resistant mutant form of HIF has been developed. 13 This stabilized, constitutively active form of HIF-1a (CA5-HIF-1a) is an attractive potential therapeutic agent. Initial experiments in a murine model were carried out delivering CA5-HIF-1a to try to correct the impaired wound healing and angiogenesis in burn wounds of aged mice. When two different methods of gene delivery for the direct application of CA5-HIF-1a failed to improve healing, an additional strategy was implemented. This was cellular therapy using bone marrowderived angiogenic cells (BMDACs). BMDACs are a heterogeneous population of cells mobilized from bone marrow, spleen and other tissues. BMDACs home to the wound under the direction of HIF-1, and particularly its transcription product stromal-derived factor-1. BMDACs express the CXCR4 receptor for stromal-derived factor-1. In the wound, BMDACs may differentiate into endothelial cells to participate in vasculogenesis or produce angiogenic factors to stimulate angiogenesis. 6, [14] [15] [16] It has been shown that growing BMDACs in the presence of the prolyl-4-hydroxylase inhibitor dimethyloxalylglycine (DMOG) can reduce oxidative destruction of HIF and preserve its function. [17] [18] [19] Therefore, the BMDACs to be used in the cellular treatment were cultured in medium containing DMOG to preserve HIF's function in the cells.
Under normoxic conditions proline residues of HIF-1a are hydroxylated. This hydroxylation allows HIF-1a to bind to the von Hippel-Lindau tumor-suppressor protein after which the complex is targeted for rapid proteolytic destruction. As the proline hydroxylases have an absolute requirement for O 2 , in hypoxic states their activity is suppressed, proline hydroxylation does not occur and HIF-1a is not degraded, allowing for HIF-1 stabilization and transcriptional activation of target genes. DMOG mimics the hypoxic state and prevents the degradation of HIF-1a. 12 
RESULTS
Effect of HIF-1a gene therapy on burn wound healing of old mice Initial experiments were performed to explore whether HIF-1a gene therapy alone would be sufficient to improve burn wound healing impaired by aging.
To determine whether AdCA5 could overcome the agingassociated impairment in burn wound healing, 22-to 24-monthold C57BL/6J mice received two 1.2-cm diameter burns on the dorsum using a heated rod with a 4-s contact time. An intradermal injection of AdCA5 (2 Â 10 8 p.f.u.) or AdLacZ (a control adenovirus encoding b-galactosidase) was administered at the site of the burn injury. The wound area was measured on days 0, 3, 7, 14 and 21 after burning using computerized planimetry. There was no evidence of faster wound closure in the AdCA5-treated group as compared with the AdLacZ control group (Figure 1) .
When the AdCA5 treatment failed, we utilized another approach with intradermal injection/electroporation using a gWIZ-CA5 DNA expression vector for constitutively active HIF-1a. This vector induced BMDAC mobilization and had promoted wound healing in a diabetic mouse model. 9 To explore whether gWIZ-CA5 treatment could correct the burn wound healing impaired by aging, 22-to 24-month-old SV129 mice received one 1.2-cm diameter burn on the dorsum using a heated rod with a 4-s contact time. We performed intradermal injection of 50 mg of gWIZ-CA5 or gWIZ-empty vector (EV) in a 50 ml saline on four sites at the perimeter of the wound followed by electroporation. Electroporation was delivered within 2 min after injection of plasmid. The wound area was measured on days 3, 7, 10, 14 and 17 after burning using computerized planimetry. Again, there was no evidence of faster wound closure in the gWIZ-CA5-treated group as compared with the gWIZ-EV control group (Figure 2) .
Effect of combined HIF-1 induction using DMOG-treated BMDACs and wound-targeted HIF-1a gene therapy When gene therapy with HIF-1a alone did not correct the impaired wound healing in aged mice, we explored the potential benefit of HIF-1a gene therapy combined with the intravenous infusion of BMDACs cultured with DMOG. DMOG is a competitive antagonist of a-ketoglutarase, an enzyme that degrades HIF during normoxia.
One burn of 1.2-cm diameter was produced on the dorsum of each mouse using a heated rod with a 4-s contact time. Immediately after surgery, CA5-HIF-1a or EV (125 mg per 50 ml saline) was injected intradermally adjacent to the upper and lower borders of each wound followed by electroporation. Electroporation was delivered with the Ichor electroporator device using proprietary murine dermal electroporation parameters (Ichor Inc., San Diego, CA, USA).
BMDACs from young mice were cultured for 4 days under endothelial growth conditions in the presence of DMOG (0.1 mM) to protect HIF-1. Cultured BMDACs (2 Â 10 6 ) or vehicle (saline) were injected via tail vein 48 h after burn injury.
The wound area was measured on days 0, 4, 7, 11, 14, 18 and 21 after burning using computerized planimetry. Compared with the untreated (EV þ saline) mice, the mice treated with CA5-HIF-1a þ BMDACs had significantly smaller wounds after burning (analysis of variance, Po0.05; Figure 3a) . By day 17, there were more mice with completely closed wounds in the treated group (w 2 , P ¼ 0.05), demonstrating that the rate of wound closure was significantly increased after combined therapy (Figure 3b ).
Tissue perfusion analysis. To compare tissue perfusion after burn injury and combined therapy, dermal blood flow was measured by serial, non-invasive laser Doppler perfusion imaging (LDPI) the same groups of mice. LDPI was performed on days 7, 11, 14 and 18 to assess blood flow in the wound area. Peak blood flow was observed on day 14 for both the treated and EV-treated mice. The dermal blood flow showed significantly increased wound perfusion on day 11 in the treated mice (analysis of variance, Po0.05; Figure 4 ).
Wound vascularization analysis.
Immunohistochemical analysis was performed on burn wound tissues harvested on day 21 post burn in the same two groups of mice using antibodies against CD31 (BD Pharmingen, Franklin Lakes, NJ, USA; Figure HIF-1a and bone marrow cell therapy J Du et al Figure 6 ). CD31
þ vessel counts showed a significant difference in vessel number per high-power field in the combined treatment group as compared with the vehicle-treated group (11±0.8 vs 6±0.6; *P ¼ 0.009, Student's t-test). In the treated group, the number of SMA þ vessels per high-power field at the center of each wound was also significantly increased compared with the EV group (17±1.7 vs 9±1.0; *Po0.001, Student's t-test).
Homing of BMDACs to burn wounds
We have shown that aging impairs homing of BMDACs to the burn wound. 6 To investigate whether combined CA5-HIF-1a transfection with BMDAC infusion could increase BMDAC homing after burn injury, we performed combined therapy experiments on aged female mice using the same protocol of burn wound healing as above. We assessed homing of BMDACs from young male mice into the burn wound of the aged female mice. Non-burned and burned tissues were harvested 8 h after i.v. injection. DNA was isolated from one half of the tissues, and quantitative PCR was performed using primers from the Sry gene, which is located on the Y chromosome and is therefore a marker for BMDACs from donor male mice.
In the absence of BMDAC injection, the Sry DNA in the burn tissue of the female mice was below the limit of detection. In the EV þ BMDAC-treated group, burn-induced BMDAC homing was 16 ± 3 copies per 1 mg genomic DNA. When the wounds were transfected with CA5-HIF-1a plasmid there was significantly increased BMDAC homing to a threefold level greater than seen when BMDACs were infused without CA5-HIF-1a transfection (48 ± 7 copies per 1 mg genomic DNA, *Po0.05, Student's t-test; Figure 7a ).
When these data were evaluated as fold increase of Sry copies in burn wound over adjacent normal dermis, the combined BMDAC infusion and CA5-HIF-1a local treatment again showed increased homing. The addition of transfection with CA5-HIF-1a increased homing threefold. In the EV þ BMDAC-treated group, there was an 8-fold increase in the homing of BMDACs to burned vs non-burned skin, whereas in the CA5-HIF-1a-treated group the ratio of homing to burned vs non-burned skin was 25-fold (*Po0.05, Student's t-test; Figure 7b ).
Transfection efficiency of CA5-HIF-1a in burn wounds
To test the transfection efficiency of CA5-HIF-1a in burn wounds, total RNA was extracted from one half of the wounds from the homing experiment and analyzed by reverse transcription quantitative PCR. The assay measured combined endogenous mouse and human CA5-HIF-1a. Transfection with CA5-HIF-1a approximately doubled mRNA expression for HIF. This was true for transfection alone and also when CA5-HIF-1a transfection was combined with the infusion of BMDACs where the increase did not reach statistical significance (Pp0.10). Group size was only four so it is not possible to conclude that the infusion of BMDACs influenced the expression of HIF (Figure 8 ).
DISCUSSION
Improving healing of burn wounds is a difficult challenge. Many experimental therapies have improved healing of excisional wounds, but not burn wounds. The associated necrosis produced by the burn wound must be cleared and replaced, making repair particularly challenging.
Initially, two attempts were made to improve healing of burn wounds in elderly mice using direct application of the constitutively active HIF-1 mutant CA5-HIF. The first approach was to utilize adenovirus CA5-HIF-1a. This method had worked previously in a limb ischemia model in diabetic mice. Adenovirus-delivered CA5-HIF-1a resulted in improved survival of critically ischemic limbs. 20 The same approach was used in the burn wounds, using the same type of CA5-HIF-1a and the same adenovirus delivery method, with no beneficial effect.
Next, another method of delivery for CA5-HIF-1a was utilized. DNA plasmid vector gWIZ was delivered by injection with electroporation. This approach had been successful in our laboratory for improving healing of excisional wounds in diabetic mice. 9 Again, this approach did not improve healing in the burn wounds of aged mice.
A similar lack of efficacy of direct treatment with CA5-HIF-1a was found when this approach was utilized to treat critical limb ischemia in aged mice. In that model, the adenovirus CA5-HIF-1a was not successful in promoting limb viability. An additional treatment with DMOG-protected BMDACs was added to the direct application of HIF, and increased survival of limbs was seen in the critical ischemia model. 18 Other groups have also found that bone HIF-1a and bone marrow cell therapy J Du et al marrow-derived progenitor cells can improve wound healing. 21 Based on this experience, we utilized the combined cell therapy/ gene therapy approach for burn wounds in the aged mice. The combined approach resulted in more rapid closure of burn wounds in the elderly mouse model. Furthermore, there was increased blood vessel density seen with immunohistochemistry for CD31 and SMA, and there was an increase in Doppler blood flow in the treated wounds as well. Next, we explored the mechanism by which the combined therapy was improving wound healing and vascularity of the burn wounds. We considered the issue of homing of BMDACs to the burn wound. Homing of BMDACs has been found to be impaired in old animals. 6 These findings suggest that BMDAC treatment with cells from young animals could benefit old animals. In the current experiments, CA5-HIF-1a treatment increased homing of BMDACs in the old animals by threefold.
The clinical use of the combined therapy would be attractive; however, the methods utilized for these experiments are not ideal for translation to clinical practice. Infusing BMDACs from a young donor into older recipients would provoke immunological rejection of the BMDACs. Ideally, methods could be developed for culturing BMDACs from elderly patients in such a HIF-1a and bone marrow cell therapy J Du et al way that the youthful capability BMDACs could be restored. The infusion of these autologous cells would not produce immune rejection and would be very suitable for clinical use.
MATERIALS AND METHODS Mice
Old C57BL/6J mice were obtained from the National Institute of Aging, NIH (Baltimore, MD, USA). Young C57BL/6J mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). The age of the old and young mice were 22-24 months and 2 months, respectively. All procedures involving mice were approved by the Johns Hopkins University Animal Care and Use Committee.
Burn wound model
Mice were anesthetized with 3% isoflurane (Baxter Healthcare Co., Deerfield, IL, USA) using an anesthesia machine, shaved on the dorsum and depilated with Nair cream (Church & Dwight Co., Princeton, NJ, USA). The burn wound was generated as previously reported. 22 Briefly, a custommade 100-g aluminum rod was heated in a 100 1C water bath for 5 min. One or two burns of 1.2-cm diameter were produced on the dorsum of each mouse. To assure burn uniformity, only the weight of the rod provided pressure to the skin surface. Contact time of 4 s measured with a metronome was chosen to produce a standardized full-thickness burn. The burns were third degree including destruction of the skin, subcutaneous tissue and the panniculous carnosus. Buprenorphine (0.1 mg kg À 1 ) was administrated subcutaneously for analgesia.
Plasmid administration CA5-HIF-1a is a constitutively active form of human HIF-1a that contains a deletion (residues 392-520) and two missense mutations (Pro567Thr and Pro658Gln). It was delivered in an adenovirus initially. Large-scale adenovirus production was performed at the NHLBI Vector Core Facility (University of Pittsburgh). 20 It was also delivered in DNA plasmid constructs. Plasmid gWIZ was obtained from Genlantis (San Diego, CA, USA). Plasmid construct gWIZ-CA5-HIF-1a was prepared as previously described. 9 Most of the experiments were performed using the plasmid construct NTC-8385-VA1-CA5 (Nature Technology Corporation, Lincoln, NE, USA). This construct we simply name CA5-HIF-1a.
The injection of the plasmid and electroporation were carried out as follows. DNA was administered using the electroporation-based TriGrid Delivery System for intradermal administration (TDS-ID, Ichor Inc.). Briefly, DNA was injected intradermally in 50 ml of saline at two points opposite each other on the sides of the wound. The intradermal blebs abut the wound. This was followed immediately by the insertion of four penetrating . BMDAC homing to the burn wound was increased by combined treatment. DMOG-treated BMDACs from young donor male C57BL/ 6J mice were administered via tail vein injection 48 h after burn injury and transfection with DNA plasmid vector (EV or CA5) into old female C57BL/6J mice. Normal skin and burn wound were harvested 8 h after cell injection. DNA was extracted, and BMDAC homing was measured using quantitative PCR for the Y chromosome-specific Sry gene relative to the autosomal NME1 gene. (a) Homing was expressed as the number of copies per 1 mg of genomic DNA (Student's t-test) and (b) the signal ratio from burn wound/normal skin. Mean±s.e.m. is shown (n ¼ 3-4 each; *Po0.05, Student's t-test).
HIF-1a and bone marrow cell therapy J Du et al electrodes at the site of intradermal DNA distribution. The electrode array comprised four penetrating electrodes arranged to form two adjoining isosceles triangles with 2.5 mm spacing and inserted to a depth of 2 mm.
Electrical stimulation was applied after electrode insertion at an amplitude of 330 V cm À 1 of electrode spacing. Total duration of stimulation was 40 ms applied over a 400-ms interval (a 10% duty cycle). After completion of pulsing, the electroporation device was removed from the tissue and the animal transferred to recovery.
Bone marrow cell isolation, culture and DMOG treatment BMDACs were prepared as described previously. 6, 18 Bone marrow was harvested from femurs and tibiae of 2-month-old male C57BL/6J mice using aseptic technique. The mononuclear cell fraction was isolated with Histopaque 1083 (Sigma-Aldrich, St Louis, MO, USA). Cells were seeded onto vitronectin-coated six-well plates (Corning, Lowell, MA, USA) and cultured in endothelial basal media supplemented with a proprietary mixture of vascular endothelial growth factor, fibroblast growth factor-2, insulin-like growth factor-1, epidermal growth factor, hydrocortisone, gentamicin, amphotericin-B, 5% fetal bovine serum and ascorbic acid (EGM2-MV; Lonza, Walkersville, PA, USA). BMDACs were cultured for 4 days in the presence of dimethylox-alylglycine (DMOG, 0.1 mM). Cell cultures were washed with phosphate-buffered saline on day 3 to remove nonadherent cells, and fresh media was added. On day 4, cells were detached with 1 mM EDTA in phosphate-buffered saline for intravenous injection. A total of 2 Â 10 6 viable cells resuspended in saline were administered to each recipient mouse 48 h after burn wounding.
Wound area measurement
On days 0, 4, 7, 11, 14, 18 and 21, the wound borders were traced in situ onto clear acetate paper by observers blinded to the protocol. Images were digitized at 1200 d.p.i. (LaserJet 3390 All in One, HP Co., Palo Alto, CA, USA). Wound areas (in pixels) were calculated using Adobe Photoshop CS3 Image software (Adobe System Inc., San Jose, CA, USA). Wound area on day 0, immediately after burn wounding, was taken as 100%. The day of complete wound closure was also recorded. Wound closure was recorded when wounds were closed and dry without eschar, with cessation of wound drainage.
LDPI
Blood flow in the wound areas was measured with a 785-nm, He-Ne scanning laser Doppler imaging device (Model LDI2-IR, Moor Instruments, Devon, UK), which utilizes a near-infrared laser diode to measure subcutaneous blood flow as a function of light scattering by moving red blood cells. The imaging system uses a low-power (2 mW) infrared laser beam to sequentially scan the tissue. For each measurement point, a signal is generated that scales linearly with tissue perfusion, defined as the product of the blood cell velocity and concentration. This quantitative signal, termed the 'laser Doppler perfusion index' (LDPI), can be represented digitally or as a two-dimensional color image on a computer screen. The colors produced illustrate the spectrum of perfusion in the wound: dark blue depicts the lowest level of perfusion and red the highest. A photographic digital image is produced simultaneously, allowing for direct anatomical comparison of corresponding areas of burn. Serial measurements were obtained on days 7, 11, 14 and 18. The scanner was positioned 20 cm above each animal. A region of interest encompassing the whole burned region was selected, and the mean blood flow was calculated using the software package (Moor LDI V5.2 software, Moor Instruments). The mean LDPI value within this area of interest was then computed.
Immunohistochemistry
Burn wounds were harvested with a rim of normal skin on day 21 after burning. Specimens were fixed with 10% formalin for 24 h, and 5-mm-thick paraffin sections were prepared. Immunohistochemistry was performed using anti-CD31 (BD Pharmingen) and anti-a-smooth muscle actin (aSMA, Sigma) antibodies, as described previously. 6 All slides were examined in a blinded manner. CD31
þ and aSMA þ vessels were counted per standard high-power field at the center of the wound directly beneath the epidermis. Vessel luminal areas were determined using Photoshop CS3 (Adobe System Inc.).
Homing of BMDACs to burn wounds BMDAC homing to the burn wound of 22-to 24-month-old female C57BL/ 6J mice was measured 8 h after intravenous injection of BMDACs from young male mice. Appearance of cells with the Y chromosome in the wounds of the female mice indicated homing. Normal and burn wound skin tissue were harvested and divided in half. Genomic DNA was isolated with DNeasy blood and tissue kit (Qiagen, Valencia, CA, USA) from half of the tissue. BMDAC homing was analyzed by quantitative real-time PCR using primers for Sry (Y-linked) and Nme1 (autosomal) gene sequences. 6, 18 Non-template controls were included in each quantitative PCR run and were devoid of amplification. Uniform template loading was confirmed with primers against the autosomal gene Nme1. Homing was calculated as the signal ratio from burn wound/normal skin for each mouse.
RNA isolation and quantitative real-time PCR assay for HIF-1a
Total RNA was extracted from the other half of each wound specimen with TRIzol (Invitrogen, Frederick, MD, USA) and treated with DNase I (Ambion, Austin, TX, USA) according to the manufacturer's protocol. Ten microgram of total RNA was used for first-strand synthesis with the iScript cDNA Synthesis System (Bio-Rad, Hercules, CA, USA). Quantitative real-time PCR was performed using iQ SYBR Green Supermix and the iCycler Real-Time PCR Detection System (Bio-Rad). The fold change in expression of HIF-1a mRNA (primer sequence: Fwd: 5 0 -CCACAGGACAGTACAGGATG-3 0 ; Rev: 5 0 -TCAAGTCGTGCTGAATAATACC-3 0 ) relative to hypoxanthine phosphoribosyltransferase 1 (HPRT1) mRNA was calculated based on the threshold cycle (C T ) for amplification as 2
, where DC T ¼ C T,HIF-1a À C T,HPRT1 .
Statistical analysis
Results are presented as mean ± standard error of mean. Differences in means between groups were analyzed for significance using Student's t-test or analysis of variance followed by Bonferroni or Tukey post hoc analysis as appropriate. HIF-1a and bone marrow cell therapy J Du et al
